References
- Stockfleth E, Terhorst D, Braathen L, et al. Guideline Subcommittee “Actinic Keratoses” of the European Dermatology Forum. Guidelines on Actinic Keratoses. [WWW document]. URL http://www.ensas.ee/docs/management_of_actinic_keratoses.pdf Accessed 10 June 2012
- Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol. 1992;55:145–57
- Babilas P, Kohl E, Maisch T, et al. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy. Br J Dermatol. 2006;154:712–18
- Sotiriou E, Apalla Z, Chovarda E, et al. Single vs. fractionated photodynamic therapy for face and scalp actinic keratoses: a randomized, intraindividual comparison trial with 12-month follow-up. J Eur Acad Dermatol Venereol. 2012;26:36–40
- Olsen EA, Abernethy ML, Kulp-Shorten C, et al. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol. 1991;24:738–43
- Cockerell CJ. New histopathological classification of actinic keratosis. J Drugs Dermatol. 2005;4:462–7
- Rossi R, Calzavara-Pinton PG, Giannetti A, et al. Italian guidelines and therapeutic algorithm for actinic keratoses. G Ital Dermatol Venereol. 2009;144:713–23
- Radakovic-Fijan S, Blecha-Thalhammer U, Kittler H, et al. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study. J Am Acad Dermatol. 2005;53:823–7
- Sotiriou E, Apalla Z, Maliamani F, et al. Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities. J Eur Acad Dermatol Venereol. 2009;23:1061–5
- Varma S, Wilson H, Kurwa HA, et al. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol. 2001;144:567–74
- Fink-Puches R, Hofer A, Smolle J, et al. Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light. J Photochem Photobiol. 1997;41:145–51
- Ibbotson SH. Adverse effects of topical photodynamic therapy. Photodermatol Photoimmunol Photomed. 2011;27:116–30
- Ghaffar SA, Clements SE, Lear JT. Epidermoid cysts mimicking recurrence of superficial basal cell carcinoma following photodynamic therapy. Clin Exp Dermatol. 2007;32:223–4
- Castano AP, Mroz P, Hamblin MR. Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer. 2006;6:535–45
- Elewski BE, Draelos Z, Dréno B, et al. Rosacea – global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. J Eur Acad Dermatol Venereol. 2011;25:188–200
- Nybaek H, Jemec GBE. Photodynamic therapy in the treatment of rosacea. Dermatol. 2005;211:135–8
- Bryld LE, Jemec GBE. Photodynamic therapy in a series of rosacea patients. J Eur Acad Dermatol Venereol. 2007;21:1199–202
- Togsverd-Bo K, Wiegell SR, Wulf HC, Hædersdal M. Short and limited effect of long-pulsed dye laser alone and in combination with photodynamic therapy for inflammatory rosacea. J Eur Acad Dermatol Venereol. 2009;23:169–243